It looks as if these particular threads on Neuromuscular’s test and subsequent management are coming to an end. However I think we should consider what happened, how people responded and where it lead us.
Experimenting on Patients without Conducting Bona Fide Research.
If this topic was about a rare condition where there is little evidence for tests or interventions then we are in a situation where we have little to fall back on. With an absence of evidence then we apply the best assessment and management strategies, based on clinical reasoning - both hypothetico-deductive reasoning and pattern recognition. At times we may fall try novel assessments and management strategies simply because doing something may be better that doing nothing. Here a site like physiobase.com is a great place to share ideas and find out what other people have tried.
However this is not the case here. Low back pain and pelvic pain are the most researched area of physiotherapy to date. In this area there are tests and treatments with adequate evidence. There is way more to learn but the research is at a maturing level of development. So when a colleague comes along and repeatedly invites an audience of physios to try out a novel test and treatment approach that has no evidence to date and where the proposal is extraordinary; who deliberately tries to get as many people involved in the testing as possible, I don’t think this is ethical. Groups of patients are being experimented upon, mostly unknowingly.
Any ethics committee would be horrified to learn that patients were being experimented on this way. If a new blood test with a novel drug treatment was handled in its preliminary stages this way all hell would break loose – and quite rightfully so.
Surely you might say the test is so harmless and relatively quick to do – so it isn’t really putting the patients at any risk. Well it may not be a likely to cause injury but it could delay the implementation of a strategy that is shown to be effective. It will most likely add confusion to the differential diagnosis. And it is costing the patient money (or if it is happening in a publicly funded clinic then it is costing the taxpayer money). And at the end of the day even if this novel approach gets some good results – this is the worst kind of evidence to fall back on – a series of anecdotes. We won’t know if it is due to placebo, the patients being polite or they were going to get better anyway. A real missed opportunity for better developing our knowledge - that was rigorously reviewed and published in the public domain
A better Way Ahead
A better way ahead would have been to have published in a peer reviewed journal a good case study or even a series of cases. Such a study that used a rigorous form of measurement could then stimulate some experimental search in the biomechanics lab. Such a look at this pelvic angle test and the relative activity of the contralateral adductor longus muscle in a group of LBP sufferers and a pain free groups might or might not show promise. One could then look at the measurement properties of the test. Then a phase one trial (small RCT) of the management. Here we are looking at years of research and the need for considerable funding. However such money is available in such an important areas of health with a group of conditions
Extraordinary Claims Need Extraordinary Evidence
Over the many decades in the life of physiotherapy many people have come up with their own tests, management which are at odds with the prevailing view. These approaches spawned BIG NAMES in physiotherapy, books on the techniques, graded continuing education courses all at great cost and time to the practitioner. And at the end of the line are we more knowledgeable? - the proponents always think they are but the evidence as it unfolds is usually less convincing. The rule here is the more extraordinary the claim the better the evidence needs to be. This rule is not about “clinging to orthodoxy” and have a closed mind to another way of looking. It is about taking stock of where the evidence currently lies. And not getting swept away on the latest fad.
As it stands there has been all this debate about this test, patients were tested with unclear results, but are we better informed from it? We await Neuromuscular’s study. Other than that I don’t think this has lead us anywhere constructive.